Edmp Inc. decreased its position in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 2.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 20,787 shares of the technology company’s stock after selling 460 shares during the quarter. Amdocs comprises about 1.6% of Edmp Inc.’s investment portfolio, making the stock its 22nd largest holding. Edmp Inc.’s holdings in Amdocs were worth $1,897,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of DOX. Cornerstone Planning Group LLC acquired a new position in shares of Amdocs during the first quarter valued at $27,000. Quarry LP boosted its holdings in shares of Amdocs by 42.2% during the first quarter. Quarry LP now owns 391 shares of the technology company’s stock valued at $36,000 after acquiring an additional 116 shares during the period. Cullen Frost Bankers Inc. acquired a new position in shares of Amdocs during the first quarter valued at $39,000. SVB Wealth LLC bought a new stake in shares of Amdocs during the first quarter valued at about $43,000. Finally, Geneos Wealth Management Inc. lifted its holdings in Amdocs by 213.9% in the first quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company’s stock worth $64,000 after purchasing an additional 477 shares during the period. Institutional investors and hedge funds own 92.02% of the company’s stock.
Amdocs Price Performance
Shares of Amdocs stock opened at $81.44 on Tuesday. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23. The company’s 50-day moving average price is $84.73 and its two-hundred day moving average price is $87.61. Amdocs Limited has a 52 week low of $78.61 and a 52 week high of $95.41. The stock has a market cap of $9.19 billion, a PE ratio of 16.52, a price-to-earnings-growth ratio of 1.34 and a beta of 0.51.
Amdocs Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a $0.527 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 annualized dividend and a yield of 2.6%. Amdocs’s payout ratio is 42.80%.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the stock. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a report on Saturday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Amdocs in a report on Wednesday, October 8th. Finally, Wolfe Research assumed coverage on shares of Amdocs in a report on Tuesday, July 8th. They issued an “outperform” rating for the company. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and an average target price of $108.00.
View Our Latest Research Report on Amdocs
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- Insider Buying Explained: What Investors Need to Know
- Why Congress Is Buying Intuitive Surgical Ahead of Earnings
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- Investing In Automotive Stocks
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.